Elevated levels of total tau (t-TAU) and phosphorylated tau (p-TAU) in CSF indicate both axonal and neuronal damage in many neurological disorders, such as Alzheimer’s disease (AD), traumatic brain injury (TBI), acute ischemic stroke (AIS), viral encephalitis, and Creutzfeldt–Jakob disease (CJD) [1]. This evidence concerns the gene MAPT and Alzheimer disease.